Insider Transactions in Q1 2025 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
4,370
-1.7%
|
$48,070
$11.96 P/Share
|
|
Feb 18
2025
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,048
-8.6%
|
$132,528
$11.96 P/Share
|
|
Feb 18
2025
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
4,646
-10.5%
|
$51,106
$11.96 P/Share
|
|
Feb 15
2025
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
16,875
+1.64%
|
-
|
|
Feb 15
2025
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
31,686
+5.76%
|
-
|
|
Feb 15
2025
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
12,086
+7.08%
|
-
|